Alternatives to Deep Genomics

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Clinical-stage precision medicine company using protein motion insights for drug discovery.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

AI-powered insights platform for life sciences and biotech workflows.

Biotech diligence research workbench

AI-driven diagnostics that convert medical images into actionable genomic insights for faster cancer treatment decisions.

Develops advanced optical technology for life sciences, enabling rapid and non-invasive diagnostics.

AI-powered platform accelerating biological research and drug discovery.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.

Biotech company focused on designing and developing novel biological solutions.

AI-powered platform for antibody discovery and development to create new medicines.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Leveraging the adaptive immune system to diagnose and treat disease.

Drug development company creating first-in-class RNA-targeting therapeutics using a proprietary platform.

AI-powered platform for understanding disease biology and accelerating drug discovery.

A global oncology company developing and commercializing innovative cancer treatments.

Developing precision medicines for inflammatory and immune-mediated diseases using AI and patient sample analysis.

AI-powered platform for real-time organ physiology to accelerate human-relevant drug discovery.

Mapping cell-cell communication at scale in human tissue.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

AI-driven drug discovery company developing novel medicines for unmet patient needs.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Developing novel therapeutics by understanding the complex interplay of biological systems.

AI-powered drug discovery and development platform for biologics.

AI-powered platform for personalized cell therapy development and manufacturing.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Advance every cancer decision.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

Gene therapy company developing transformative treatments for severe genetic diseases.

Gene therapy company developing treatments for rare inherited diseases.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

AI-powered drug discovery platform leveraging nature's chemistry for novel therapeutics.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Clinical-stage biotech developing AI-driven metabolic immunotherapies for cancer and autoimmune diseases.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

A biotechnology company focused on extending healthy human lifespan by targeting the biological causes of aging.

Develops a computational model of the human body for drug discovery and development.

Personalized computational drug screening for rare diseases using patient genetics and automation.

AI-powered drug discovery platform for GPCR targets, accelerating development and reducing risk.

Global marketplace connecting researchers with human biospecimens for life science research.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

Biosynthesis of cannabinoids and psychedelics using advanced biotechnology.

AI-powered platform for designing novel molecular structures for new medicines.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

Biotechnology company

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

Biostax provides a cloud-based platform for life sciences research, enabling data integration and analysis.

SNIPR Biome is a clinical-stage company developing CRISPR-based therapeutics to precisely target and eliminate specific bacteria in the human microbiome.

Biotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.

Life science company pioneering drug discovery with AI and advanced technologies.